seobhushan (51)

1
Ophthalmic Viscosurgical Devices Market is
projected to reach CAGR 3.1 by 2027
2
Key Insights from Ophthalmic Viscosurgical
Devices Market

• The global ophthalmic viscosurgical devices
  market size has witnessed growth in multiple
  folds supported by the presence of leading
  industry players that are actively working
  towards introducing a wide variety of advanced
  products.
• Companies are investing heavily in research and
  development activities to meet industry needs and
  to expand their global presence. For example, in
  March 2019, American-Swiss medical company, Alcon
  announced the purchase of PowerVision Inc.- a
  firm that is engaged in the development of
  fluid-based solutions for cataract surgery. The
  acquisition focused on meeting the needs of
  increasing number of cataract surgery patients
  and help Alcon expanding its customer base and
  strengthening its position in the market.
• Considering various product types, the market is
  bifurcated into cohesive, dispersive, and
  combined OVDs. The combined OVD segment has
  witnessed considerable adoption over time as it
  offers the benefits of both dispersive and
  cohesive agents in a single vial, making it more
  cost-effective for eye surgery. Combined
  ophthalmic viscosurgical devices could be used
  for each stage of the phaco procedure and may
  prove to be highly economical.

3

Latest Research Report On Ophthalmic
Viscosurgical Devices Market _at_ https//www.gminsig
hts.com/industry-analysis/ophthalmic-viscosurgical
-devices-market Request for a sample of this
research report _at_ https//www.gminsights.com/reque
st-sample/detail/1134
4
Major Companies in Ophthalmic Viscosurgical
Devices Market

• Alcon
• Amring Pharmaceuticals
• Bausch Lomb Incorporated
• Bohus Biotech AB

5
Industry Coverage

6
Stay In Touch Website www.gminsights.com Soci
al Media